PHASE 2 STUDY

Clinical trials for PHASE 2 STUDY explained in plain language.

Never miss a new study

Get alerted when new PHASE 2 STUDY trials appear

Sign up with your email to follow new studies for PHASE 2 STUDY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1

New shot aims to stop hidden leukemia in its tracks

Disease control Not yet recruiting

This study tests whether a drug called blinatumomab, given as a simple injection under the skin, can control small amounts of leftover leukemia cells (called measurable residual disease, or MRD) in adults with B-cell acute lymphoblastic leukemia. The goal is to prevent the cancer…

Matched conditions: PHASE 2 STUDY

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Jun 27, 2026 12:29 UTC

PHASE 2 STUDY

Get alerted when new PHASE 2 STUDY trials appear

New shot aims to stop hidden leukemia in its tracks